Adverse events Complications reported · Patients with thumb (trapeziometacarpal joint) osteoarthritis
Trapeziectomy with ligament reconstruction and tendon interposition… showed no clear difference in adverse events complications reported compared with trapeziectomy and interpositional arthroplasty (T and IA) (moderate certainty).
1 finding from 1 review
Adverse events Complications reported · Patients with thumb (trapeziometacarpal joint) osteoarthritis
Trapeziectomy with interpositional arthroplasty (T and IA) showed no clear difference in adverse events Complications reported compared with trapeziometacarpal joint replacement (Swanson) (low certainty).
1 finding from 1 review
Adverse events Complications reported · Patients with thumb (trapeziometacarpal joint) osteoarthritis
Trapeziectomy with interpositional arthroplasty (T and IA) showed no clear difference in adverse events Complications reported compared with trapeziectomy (T) (moderate certainty).
1 finding from 1 review
Adverse events Complications reported · Patients with thumb (trapeziometacarpal joint) osteoarthritis
Trapeziectomy with ligament reconstruction and tendon interposition… showed no clear difference in adverse events Complications reported compared with trapeziectomy (T) (low certainty).
1 finding from 1 review
Serious adverse events Adverse events · patients with chronic obstructive pulmonary disease
Indacaterol showed no clear difference in serious adverse events Adverse events compared with twice‐daily long‐acting beta2‐agonists (moderate certainty).
1 finding from 1 review
Intervention not reported
Incidence of adverse events ‐ overall · children with HIV infection aged 12 years and under
The intervention showed no clear difference in incidence of adverse events ‐ overall (moderate certainty).
1 finding from 1 review
Intervention not reported
Discontinuation due to adverse events · Patients with fibromyalgia
It is very uncertain whether the intervention changes discontinuation due to adverse events (very low certainty).
1 finding from 1 review
Serious adverse events(up to 6 months) · children and young people with JIA
Methotrexate showed no clear difference in serious adverse events(up to 6 months) compared with placebo (low certainty).
1 finding from 1 review
Adverse events: serious adverse events · adults with cystic fibrosis
1 finding from 1 review
Serious adverse events at up to day 28 · non‐hospitalised adults with mild COVID‐19
Remdesivir and standard care may leads to lower serious adverse events at up to day 28 compared with standard care (plus/minus placebo) (low certainty).
1 finding from 1 review
Serious adverse events at up to day 28 · hospitalised individuals with COVID‐19 (moderate to severe disease)
Remdesivir and standard care showed no clear difference in serious adverse events at up to day 28 compared with standard care (plus/minus placebo) (low certainty).
1 finding from 1 review
Adverse events: Shoulder complications · adults with minimally displaced or displaced (2‐part or 3‐part) proximal humeral fractures treated non‐surgically (5 trials)
1 finding from 1 review
Adverse events ‐ superficial infection · adults with open long bone fractures of the upper and lower limbs
It is very uncertain whether timing of wound closure (immediate changes adverse events ‐ superficial infection compared with delayed) (very low certainty).
1 finding from 1 review
Serious adverse events within 6 months · SARS‐CoV‐2 uninfected people without defined exposure, or with potential exposure to SARS‐CoV‐2
It is very uncertain whether casirivimab/imdevimab changes serious adverse events within 6 months compared with placebo (very low certainty).
1 finding from 1 review
Other adverse events and complications · people with liver metastases
The review found no eligible studies for this question.
1 finding from 1 review
Other adverse events and complications · people with liver metastases
The review found no eligible studies for this question.
1 finding from 1 review
Constipation · people with moderate to severe cancer pain
1 finding from 1 review
Constipation · people with moderate to severe cancer pain
The review found no eligible studies for this question.
1 finding from 1 review
Constipation · people with moderate to severe cancer pain
It is very uncertain whether hydromorphone changes specific adverse events – constipation compared with oxycodone (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adult men with premature ejaculation
SSRI may leads to higher study withdrawal due to adverse events compared with placebo (low certainty).
1 finding from 1 review